CLVT Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

603.68M

-8.95%

0.167

-20.68%

574.80M

-3.18%

0.138

-1.75%

607.74M

-2.2%

0.185

+2.76%

Estimates Revision

The market is revising Upward the revenue expectations for Clarivate Plc (CLVT) for FY2025, with the revenue forecasts being adjusted by 2.26% over the past three months. During the same period, the stock price has changed by -5.12%.

Revenue Estimates for FY2025

Revise Upward

+2.26%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-5.12%

In Past 3 Month

6 Analyst Rating

Wall Street analysts forecast CLVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLVT is 4.80 USD with a low forecast of 4.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

4 Hold

1 Sell

Hold

Current: 0.000

Low

4.00

Averages

4.80

High

6.00

Current: 0.000

Low

4.00

Averages

4.80

High

6.00

Goldman Sachs

Buy

Neutral

downgrade

2026-01-08

New

Reason

Goldman Sachs

Price Target

2026-01-08

New

downgrade

Buy

Neutral

Reason

Goldman Sachs downgraded Clarivate to Neutral from Buy with a price target of $3.60, down from $4.20. The firm says the company's "Value Creation Plan" will require an extended timeframe to produce meaningful improvements in organic revenue growth. Clarivate's revenue growth will be slow by increasing competition from AI-native entrants across its segments and its limited ability to drive pricing increases beyond low-single-digits, the analyst tells investors in a research note.

Morgan Stanley

Equal Weight -> Underweight

downgrade

$5 -> $3

2025-12-17

Reason

Morgan Stanley

Price Target

$5 -> $3

2025-12-17

downgrade

Equal Weight -> Underweight

Reason

Morgan Stanley downgraded Clarivate to Underweight from Equal Weight with a price target of $3, down from $5. The firm sees continued share underperformance for Clarivate as its turnaround "continues to struggle." The company faces tight budgets and competition, and its strategic review will not yield much value, the analyst tells investors in a research note.

Goldman Sachs

Buy

downgrade

2025-10-31

Reason

Goldman Sachs

Price Target

2025-10-31

downgrade

Buy

Reason

Goldman Sachs lowered the firm's price target on Clarivate to $4.20 from $4.80 and keeps a Buy rating on the shares.

Goldman Sachs

Buy

downgrade

2025-10-30

Reason

Goldman Sachs

Price Target

2025-10-30

downgrade

Buy

Reason

Goldman Sachs lowered the firm's price target on Clarivate to $4.20 from $4.80 and keeps a Buy rating on the shares.

Wolfe Research

Peer Perform

initiated

$4 -> $5

2025-09-03

Reason

Wolfe Research

Price Target

$4 -> $5

2025-09-03

initiated

Peer Perform

Reason

Wolfe Research initiated coverage of Clarivate with a Peer Perform rating and $4-$5 fair value range. The company has a strong market share with limited competition, but faces risks from tighter university and healthcare budgets, artificial intelligence disintermediation, and a relatively high net leverage ratio, the analyst tells investors in a research note.

Jefferies

Buy

Hold

downgrade

2025-07-18

Reason

Jefferies

Price Target

2025-07-18

downgrade

Buy

Hold

Reason

Jefferies downgraded Clarivate to Hold from Buy with a price target of $4.50, down from $5.20. The firm says that while the company's fiscal Q1 results were better than expected, investors are underestimating the time it will take for Clarivate to unlock value, either through organic means or divestitures. It sees the company's 2026 revenue as flat with 2025 levels with risk to the business from the current administration's plans to cut funding for the National Institutes of Health and post secondary education. As such, Jefferies sees Clarivate trading sideways in the near-term.

Valuation Metrics

The current forward P/E ratio for Clarivate PLC (CLVT.N) is 4.88, compared to its 5-year average forward P/E of 14.97. For a more detailed relative valuation and DCF analysis to assess Clarivate PLC 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

14.97

Current PE

4.88

Overvalued PE

24.92

Undervalued PE

5.01

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.55

Current EV/EBITDA

6.48

Overvalued EV/EBITDA

18.07

Undervalued EV/EBITDA

7.03

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.29

Current PS

0.89

Overvalued PS

5.86

Undervalued PS

0.72

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 182.82% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CLVT News & Events

Events Timeline

No data

News

3.5

01-06PRnewswire

Clarivate Unveils 2026 Drugs to Watch Report Highlighting 11 Transformative Therapies

9.5

01-06Newsfilter

Clarivate Unveils 2026 Drugs to Watch Report Highlighting 11 Therapies Set to Transform Patient Care

4.5

2025-12-24Benzinga

S&P 500 Hits Record Highs as Market Sentiment Improves

People Also Watch

Frequently Asked Questions

What is Clarivate PLC (CLVT) stock price today?

The current price of CLVT is 3.425 USD — it has decreased -1.3 % in the last trading day.

What is Clarivate PLC (CLVT)'s business?

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.

What is the price predicton of CLVT Stock?

What is Clarivate PLC (CLVT)'s revenue for the last quarter?

Clarivate PLC revenue for the last quarter amounts to 623.10M USD, increased 0.14 % YoY.

What is Clarivate PLC (CLVT)'s earnings per share (EPS) for the last quarter?

Clarivate PLC. EPS for the last quarter amounts to -0.04 USD, decreased -55.56 % YoY.

What changes have occurred in the market's expectations for Clarivate PLC (CLVT)'s fundamentals?

How many employees does Clarivate PLC (CLVT). have?

Clarivate PLC (CLVT) has 12000 emplpoyees as of January 09 2026.

What is Clarivate PLC (CLVT) market cap?

Today CLVT has the market capitalization of 2.30B USD.